Inactive Instrument

Luminex Corporation

Equities

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Luminex Corporation Reports Earning Guidance for Second Quarter and for the Year 2020

May 05, 2020 at 02:35 am IST

Luminex Corporation reported earning guidance for the second quarter 2020. For the quarter, revenue forecasted to be at or above $105 million, with growth in excess of 26%. For the year 2020, The company expects revenue to be above the top end of previously communicated guidance range of $352 - $362 million.

Latest news about Luminex Corporation

Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	28/23/28	CI
Transcript : Cytek Biosciences, Inc., Luminex Corporation - M&A Call	14/23/14
Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	13/23/13	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	15/21/15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	15/21/15	CI
Luminex Corporation Announces Executive Changes	14/21/14	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	14/21/14	CI
DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	14/21/14	CI
Update: Middlesex Water to Replace Luminex in S&P SmallCap 600 -- Shares Jump in Pre-Market Trading	13/21/13	MT
Middlesex Water : to Replace Luminex in S&P SmallCap 600	13/21/13	MT
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Biotechnology Index	13/21/13	CI
Middlesex Water : S&P Dow Jones Indices Says Middlesex Water Company (MSEX) to Replace Luminex (LMNX) in S&P SmallCap 600 from July 15	13/21/13	MT
Luminex : Gets US Regulatory Approval for Acquisition by DiaSorin	09/21/09	MT
Luminex : Quarterly Dividend Unchanged at $0.10 Per Share, Payable July 8 to Stockholders of Record on June 17	21/21/21	MT
Luminex Corporation Declared Cash Dividend for the Second Quarter of 2021, Payable on July 8, 2021	21/21/21	CI
Luminex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	05/21/05	CI
LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	13/21/13	MT
LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	13/21/13	MT
Sector Update: Health Care Stocks Slip as Midday Gains Evaporate	13/21/13	MT
Sector Update: Health Care Stocks Drifting Higher This Afternoon	12/21/12	MT
Sector Update: Health Care	12/21/12	MT

Chart Luminex Corporation

Duration

Period

More charts

Company Profile

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.61B

Other Advanced Medical Equipment & Technology